Navigation Links
NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT)
Date:3/3/2010

The objective of the PACT program is to continue to advance cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies. Five (5) Cell Processing Facilities will support translational research in novel cell therapies, to advance the field of cellular therapy, and to enable scientifically meritorious basic science research to reach the clinical trial stage.

(PRWEB) March 3, 2010 -- On January 15, 2010, five (5) Cell Processing Facilities: Baylor College of Medicine Center for Cell and Gene Therapy, Beckman Research Institute of City of Hope, Center for Applied Technology Development, Center for Human Cell Therapy Boston, University of Minnesota, Molecular and Cellular Therapeutics Facility, The University of Wisconsin - Madison, Waisman Clinical BioManufacturing Facility and a Coordinating Center, The EMMES Corporation, were each awarded a five year contract. “We are very excited with continuing to support the cell therapy community and implementing new initiatives aimed at advancing the development of new cell therapies,” says NHLBI Project Officer Traci Heath Mondoro, PhD.


The objective of the PACT program is to continue to advance cellular therapy research in the areas of regeneration of damaged/diseased tissues, organs, and biologic systems, and targeted treatments for serious diseases without effective therapies. The Cell Processing Facilities will support translational research in novel cell therapies, to advance the field of cellular therapy, and to enable scientifically meritorious basic science research to reach the clinical trial stage.

This morning's announcement detailed a number of PACT’s educational initiatives, which demonstrate PACT’s commitment to the cell therapy community. These initiatives include educational web seminars, workshops and information/education sessions at upcoming scientific conferences.

Applications
PACT is currently accepting and evaluating applications. Applications for manufacturing support can be submitted through the PACT website at www.pactgroup.net.

About PACT
The PACT Group is an NHLBI-funded initiative that is committed to the advancement of effective cell therapies. PACT supports the development of novel somatic cell therapy products by providing production assistance to the cell therapy community, as well as educational training via web seminars and at meetings. Production assistance is provided through the funded contract manufacturing of therapeutic cell products at PACT processing facilities. These facilities offer scale-up capability and expertise in the translational development needed to produce cell therapy products under cGMP and cGTP regulations. PACT’s educational training focuses on: translational development/scale-up and manufacture of cell therapy products; and quality assurance and regulatory issues.

More information about PACT is available at www.pactgroup.net

Contact:
PACT, Rockville, MD
Jamie Winestone or Debbie Wood
phone: 301-251-1161

This project has been funded in whole or in part with Federal funds from the NHLBI, NIH under Contract No. HHSN268201000006C

# # #

Read the full story at http://www.prweb.com/releases/PACTGroup/CellTherapy/prweb3677854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. CIGNA Group Insurance Shows Consumers Theres More to Life Through a New Consumer Education Toolkit
4. HIDA Calls for Scrutiny of Group Purchasing Organization Distributor Fee Structure
5. New Research Uncovers how to Build and Maintain an Effective Competitive Intelligence Group
6. AMERIGROUP to Acquire Memphis Health Plan
7. Securians Minnesota Life Continues to Climb Group Life Rankings
8. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
9. Are Bargaining Groups Hired by Independent Drugstores Causing Payment Delays to Pharmacies?
10. Group B Strep: A Threat to Newborns That Doesnt Have to Be
11. Cynosure to Present at the Maxim Group Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NIH/NHLBI-funded PACT Group Announces the Renewal of Production Assistance for Cellular Therapies (PACT) 
(Date:3/29/2017)... ... March 29, 2017 , ... ... developing an ANSI-approved, consensus-based American National Standard for Good Manufacturing Practices (GMPs) ... first ANSI-approved GMP standard for dietary supplements this spring, is hiring an ...
(Date:3/29/2017)... CT (PRWEB) , ... March 29, 2017 , ... HealthCareMandA.com ... —on Thursday, April 20, 2017, at 1:00 PM ET. A recording of the webinar ... the Interactive Webinar Series. , Home health and hospice companies are still popular targets ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who manage some ... Time Square, New York. , The program will be led by co- ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is the annual American ... Diabetes Risk Test to find out if they are at risk for developing Type ... up the evening sky by programming the LAX pylons the color red. Downtown’s U.S. ...
(Date:3/28/2017)... DC (PRWEB) , ... March 28, 2017 , ... ... on elected representatives in state legislatures and Congress to protect parental rights and ... public health and safety in America. , The demonstration coincides with a press ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... The global emerging cancer diagnostics market is ... 2016 to 2023 and reach a figure of $6.34 ... a chronic disease and is affecting a huge population. ... This report is focused on emerging cancer diagnostics market ... propelled due to factors such as: increasing number of ...
(Date:3/28/2017)... 28, 2017  Medeon Biodesign, Inc., a ... pleased to announce that the Company led and ... Orthopedics, Inc., a San Jose, CA ... for orthopedic extremity applications.  The ... primarily due to procedure volume growth, lifestyle influences ...
(Date:3/28/2017)... 28, 2017  "US Cancer Generics Market Outlook ... indicators and trend analysis related to the emergence ... pharmaceutical market in US. The report analyzes various ... on cancer generics drugs in recent years. The ... billions of dollars for various stake holders involved ...
Breaking Medicine Technology: